Influence of the CYP4F2 polymorphism on the risk of hemorrhagic complications in coumarin-treated patients

From the Institute of Pharmacy & Pharmacology (Chen), University of South China, the Department of Pathology (Sun), First Affiliated Hospital of University of South China, the Department of Pharmacy (Li, Pan, Zhou), Second Affiliated Hospital of University of South China, Hengyang, the Center of Clinical Pharmacology (Yang), Third Xiangya Hospital, Central South University, Changsha, China

From the Institute of Pharmacy & Pharmacology (Chen), University of South China, the Department of Pathology (Sun), First Affiliated Hospital of University of South China, the Department of Pharmacy (Li, Pan, Zhou), Second Affiliated Hospital of University of South China, Hengyang, the Center of Clinical Pharmacology (Yang), Third Xiangya Hospital, Central South University, Changsha, China

From the Institute of Pharmacy & Pharmacology (Chen), University of South China, the Department of Pathology (Sun), First Affiliated Hospital of University of South China, the Department of Pharmacy (Li, Pan, Zhou), Second Affiliated Hospital of University of South China, Hengyang, the Center of Clinical Pharmacology (Yang), Third Xiangya Hospital, Central South University, Changsha, China

From the Institute of Pharmacy & Pharmacology (Chen), University of South China, the Department of Pathology (Sun), First Affiliated Hospital of University of South China, the Department of Pharmacy (Li, Pan, Zhou), Second Affiliated Hospital of University of South China, Hengyang, the Center of Clinical Pharmacology (Yang), Third Xiangya Hospital, Central South University, Changsha, China

From the Institute of Pharmacy & Pharmacology (Chen), University of South China, the Department of Pathology (Sun), First Affiliated Hospital of University of South China, the Department of Pharmacy (Li, Pan, Zhou), Second Affiliated Hospital of University of South China, Hengyang, the Center of Clinical Pharmacology (Yang), Third Xiangya Hospital, Central South University, Changsha, China

From the Institute of Pharmacy & Pharmacology (Chen), University of South China, the Department of Pathology (Sun), First Affiliated Hospital of University of South China, the Department of Pharmacy (Li, Pan, Zhou), Second Affiliated Hospital of University of South China, Hengyang, the Center of Clinical Pharmacology (Yang), Third Xiangya Hospital, Central South University, Changsha, China